<DOC>
	<DOCNO>NCT02616822</DOCNO>
	<brief_summary>Arterial Hypertension ( HBP ) high prevalence low rate control , consider major modifiable risk factor one important public health problem . Mortality cardiovascular disease increase progressively increase blood pressure ( BP ) linear , continuous independent . The pathophysiological mechanism involve pathogenesis hypertension exhibit metabolic abnormality , relate endothelial dysfunction . Resveratrol , polyphenol stilbene derive various specie plant , food , mainly present red wine grape , show protective effect cardiovascular disease , prevent damage cause oxidative stress , decrease plasma lipid inhibit formation atherosclerotic plaque ; protective effect vascular endothelium , increase release nitric oxide decrease production free radical animal model , human study limit insufficient clarify possible effect trans-resveratrol ( biologically active form ) endothelial function , blood pressure central aortic pressure treat hypertensive individuals.The aim study evaluate acute effect trans-resveratrol supplementation endothelial function treat hypertensive patient .</brief_summary>
	<brief_title>Effects Trans-Resveratrol Endothelial Function Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Resveratrol</mesh_term>
	<criteria>Outpatients age 45 65 year , gender . Patients previous diagnosis hypertension . Patients endothelial disfunction . Stable use antihypertensive treatment least 2 month . Patients food consumption maintain least 4 week , orient limit intake food rich polyphenols , peanut butter , cranberry , blackberry , red grape , red wine , green tea chocolate . Signing consent form . Smoking . Diabetes Mellitus / use insulin oral hypoglycemic agent . Hormone replacement therapy . Use ÃŸblockers statin . Sleep apnea . Changes thyroid function , chronic renal liver disease . Clinically evident coronary heart disease previous myocardial infarction / revascularization , clinical sign heart failure , cardiac arrhythmia , symptomatic clinically significant valvular disease , prior stroke . History drug alcohol abuse . Presence kind eat disorder ; Diets restrict choice ( vegetarianism , carbohydrate restriction ) ; Use nutritional supplement ( vitamin , mineral ) , least seven ( 7 ) day prior study ; Patients severe illness lifethreatening condition , disease therapy , opinion investigator , may adversely affect result , interfere study objective jeopardize safety patient .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>hypertension</keyword>
	<keyword>endothelium</keyword>
	<keyword>resveratrol</keyword>
	<keyword>clinical trial</keyword>
</DOC>